Home / Inspections / 1218229

FDA Inspection 1218229 — Boston Medical Center

Boston Medical Center — FEI 1273232

The FDA completed an inspection of Boston Medical Center on September 12, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)

Facility

Other inspections at this facility

  • 1270738 (NAI Fri May 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091871 (NAI Thu May 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 963517 (VAI Fri Mar 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864614 (NAI Mon Feb 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 759061 (VAI Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources